相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of SDF-1 chemokine and its receptors CXCR4 and CXCR7 involved in EMT of prostate cancer
Martyna Parol-Kulczyk et al.
CYTOKINE (2022)
The emerging roles of Gα12/13 proteins on the hallmarks of cancer in solid tumors
Suhail Ahmed Kabeer Rasheed et al.
ONCOGENE (2022)
GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation
Jawed Akhtar Siddiqui et al.
BONE RESEARCH (2022)
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression
Kristen Fousek et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update
Isaac J. Powell et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
Youmna Kfoury et al.
CANCER CELL (2021)
Mechanism of tumour microenvironment in the progression and development of oral cancer
Mohd Mughees et al.
MOLECULAR BIOLOGY REPORTS (2021)
Genomic and phenotypic heterogeneity in prostate cancer
Michael C. Haffner et al.
NATURE REVIEWS UROLOGY (2021)
Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling
Jawed A. Siddiqui et al.
BONE (2021)
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao et al.
MOLECULAR CANCER (2021)
Research Trends and Regulation of CCL5 in Prostate Cancer
Renlun Huang et al.
ONCOTARGETS AND THERAPY (2021)
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
Lauren Brady et al.
NATURE COMMUNICATIONS (2021)
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Sugandha Saxena et al.
CANCER AND METASTASIS REVIEWS (2021)
Kinase Inhibitors' Effects on Innate Immunity in Solid Cancers
Chunying Peng et al.
CANCERS (2021)
GPR30 knockdown weakens the capacity of CAF in promoting prostate cancer cell invasion via reducing macrophage infiltration and M2 polarization
Ran Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
Baotong Zhang et al.
NATURE COMMUNICATIONS (2021)
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou et al.
CANCERS (2021)
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Hans Raskov et al.
FRONTIERS IN ONCOLOGY (2021)
Prostate Cancer Progression: as a Matter of Fats
Natalia Scaglia et al.
FRONTIERS IN ONCOLOGY (2021)
Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells
Christina Sakellariou et al.
BJU INTERNATIONAL (2020)
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
MiR-130b/TNF-alpha/NF-kappa B/VEGFA loop inhibits prostate cancer angiogenesis
H. Q. Mu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
The effects of L-NAME on DU145 human prostate cancer cell line: A cytotoxicity-based study
S. Kacar et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2020)
Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis
Chih-Heng Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Extracellular Histone Promotes Prostate Cancer Migration and Epithelial-Mesenchymal Transition through NF-κB-Mediated Inflammatory Responses
Lei Chen et al.
CHEMOTHERAPY (2020)
Modulation of CXC-motif chemokine receptor 7, but not 4, expression is related to migration of the human prostate cancer cell LNCaP: regulation by androgen and inflammatory stimuli
Lu Yu et al.
INFLAMMATION RESEARCH (2020)
Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells
Shui Fu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway
Yang Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
Tianyu Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer
Zhijian Yan et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
Jessica E. Hawley et al.
PROSTATE (2020)
miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer
Jin-Chun Qi et al.
FRONTIERS IN ONCOLOGY (2020)
CCL2/CCR2 signaling in cancer pathogenesis
Qiongyu Hao et al.
CELL COMMUNICATION AND SIGNALING (2020)
CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
Renlun Huang et al.
CELL DEATH & DISEASE (2020)
Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression
Nerymar Ortiz-Otero et al.
Oncotarget (2020)
Tumor-Associated Macrophages (TAM) are recruited to the aging prostate epithelial lesions and become intermingled with basal cells
Hipacia Werneck-Gomes et al.
ANDROLOGY (2020)
Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
Maria E. Reyes et al.
FRONTIERS IN IMMUNOLOGY (2020)
CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
Wen Zhang et al.
CANCER COMMUNICATIONS (2020)
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Timothy O. Adekoya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role of Chemokines in the Biology of Cholangiocarcinoma
Alessandra Caligiuri et al.
CANCERS (2020)
Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells
Emarndeena H. Cheteh et al.
CELL DEATH DISCOVERY (2020)
Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients' survival and responses to androgen deprivation therapies in Indonesian patients cohort
Prahara Yuri et al.
PROSTATE INTERNATIONAL (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Irina Larionova et al.
FRONTIERS IN ONCOLOGY (2020)
Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression
Bikash Chandra Jena et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
Yi Shi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
Ralf Hass et al.
CANCERS (2020)
Cytokines in the Treatment of Cancer
Kevin C. Conlon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Consequences of interleukin 1β-triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4+ infiltration mimics human proliferative inflammatory atrophy
Arya Ashok et al.
PROSTATE (2019)
Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
Guangchen Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Yuan Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Shangze Li et al.
CANCER RESEARCH (2019)
Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy
Sumanta K. Pal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2
Xiaodong Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Infiltrating CD4+T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling
Peng Xiang et al.
PROSTATE (2019)
An IL-2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune response
Oliver Rogers et al.
PROSTATE (2019)
IL-8 protects prostate cancer cells from GSK-3β-induced oxidative stress by activating the mTOR signaling pathway
Yi Sun et al.
PROSTATE (2019)
Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells
Ik-Hwan Han et al.
PROSTATE (2019)
Hypoxia-inducible factor-1 induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells
Santosh Kumar Singh et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
Kouji Izumi et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Interleukin-24 Transduction Modulates Human Prostate Cancer Malignancy Mediated by Regulation of Anchorage Dependence
Shotaro Maehana et al.
ANTICANCER RESEARCH (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Circulating inflammation markers and prostate cancer
Henrik Ugge et al.
PROSTATE (2019)
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer
Torben Frostrup Hansen et al.
TRANSLATIONAL ONCOLOGY (2019)
IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway
Xi Liu et al.
CELL DEATH & DISEASE (2019)
Coping with chemoresistance in prostate cancer-co-targeting of adipose stromal cells?
Divya Bhagirath et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2019)
Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Associated Fibroblast Inactivation with Peptide Assembly-Based Nanosystem
Jiayan Lang et al.
ACS NANO (2019)
Prostate Cancer The Role of Inflammation and Chemokines
Aradhana Rani et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway
Yin-Gi Jang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis
Masahito Watanabe et al.
PROSTATE (2019)
Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma
Chenlong Li et al.
CELL DEATH & DISEASE (2019)
Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
Diletta Di Mitri et al.
CELL REPORTS (2019)
Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression
Mohit Kumar Jolly et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The role of PKC and PKD in CXCL12 directed prostate cancer migration
I Hamshaw et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
G?-13 induces CXC motif chemokine ligand 5 expression in prostate cancer cells by transactivating NF-?B
Wei Kiang Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies
Denisa Baci et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway
Dai-Yu Sun et al.
LIFE SCIENCES (2019)
Polyphyllin I induces cell cycle arrest in prostate cancer cells via the upregulation of IL6 and P21 expression
Denglu Zhang et al.
MEDICINE (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment
Adaugo Q. Ohandjo et al.
SCIENTIFIC REPORTS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing
U-Ging Lo et al.
CANCER RESEARCH (2019)
Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance
Fei Su et al.
ONCOGENE (2019)
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
Federico Bocci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
Timothy E. Krueger et al.
PROSTATE (2019)
M2 macrophages and regulatory T cells in lethal prostate cancer
Ann Erlandsson et al.
PROSTATE (2019)
Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer
Jae Won Yun et al.
TRANSLATIONAL ONCOLOGY (2019)
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente et al.
FRONTIERS IN IMMUNOLOGY (2019)
Toward Normalization of the Tumor Microenvironment for Cancer Therapy
Jie Zheng et al.
INTEGRATIVE CANCER THERAPIES (2019)
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta et al.
FRONTIERS IN IMMUNOLOGY (2019)
RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis
Yang Bai et al.
THERANOSTICS (2019)
Plant Enzymes Decrease Prostate Cancer Cell Numbers and Increase TNF-α In Vivo: A Possible Role in Immunostimulatory Activity
Yeun-Hwa Gu et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCE (2019)
Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
Makito Miyake et al.
THERANOSTICS (2019)
IL-1 and IL-1 regulatory pathways in cancer progression and therapy
Alberto Mantovani et al.
IMMUNOLOGICAL REVIEWS (2018)
GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers
Suhail Ahmed Kabeer Rasheed et al.
ONCOGENE (2018)
Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization
Carlo Sorrentino et al.
CANCER RESEARCH (2018)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy
Angela Rita Elia et al.
CLINICAL CANCER RESEARCH (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2-and CXCL8-mediated cancer cell migration
Bianca Cioni et al.
MOLECULAR ONCOLOGY (2018)
The Heterogeneity of Prostate Cancer: A Practical Approach
Yuri Tolkach et al.
PATHOBIOLOGY (2018)
Intratumor heterogeneity in prostate cancer
Shalini S. Yadav et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling
Federico Bocci et al.
Oncotarget (2018)
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
Arianna Calcinotto et al.
NATURE (2018)
Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity
Gianluca D'Agostino et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location
Harold Evelyn Taitt
AMERICAN JOURNAL OF MENS HEALTH (2018)
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
Giorgio Stanta et al.
FRONTIERS IN MEDICINE (2018)
Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
Lucy V. Ireland et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Stromal factors involved in human prostate cancer development, progression and castration resistance
Noemi Eiro et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition
Q. Zhang et al.
ONCOGENE (2017)
Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis
Aerken Maolake et al.
ONCOTARGET (2017)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang et al.
NATURE MEDICINE (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
Li Yang et al.
SEMINARS IN CANCER BIOLOGY (2017)
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Akash Patnaik et al.
CANCER DISCOVERY (2017)
LncRNA ANCR down-regulation promotes TGF-β-induced EMT and metastasis in breast cancer
Zhongwei Li et al.
Oncotarget (2017)
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha et al.
THERANOSTICS (2017)
CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
Jawed Akhtar Siddiqui et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism
Jawed A. Siddiqui et al.
SCIENTIFIC REPORTS (2017)
Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth
Ke-Qin Yang et al.
BMC CANCER (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking
Valentina Cecchinato et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
M. Pietila et al.
CANCER LETTERS (2016)
TGF-β Signaling in Cancer
Viqar Syed
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Role of interleukin-6 in cancer progression and therapeutic resistance
Neeraj Kumari et al.
TUMOR BIOLOGY (2016)
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
Victor Laurent et al.
NATURE COMMUNICATIONS (2016)
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Naoki Oshimori et al.
CELL (2015)
Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer
Aimalie L. Hardaway et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Long Non-coding RNAs (LncRNA) Regulated by Transforming Growth Factor (TGF) β LncRNA-HIT-MEDIATED TGFβ-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA
Edward J. Richards et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Chemokine System in Innate Immunity
Caroline L. Sokol et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
Daniel P. Nguyen et al.
BJU INTERNATIONAL (2014)
A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
Ji-hang Yuan et al.
CANCER CELL (2014)
Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments
C. R. Balistreri et al.
CANCER GENE THERAPY (2014)
Low dose of interferon-α improves the clinical outcomes of docetaxel in patients with castration-resistant prostate cancer: A pilot study
Yun-Fei Li et al.
ONCOLOGY LETTERS (2014)
Hypoxia increases CX3CR1 expression via HIF-1 and NF-κB in androgen-independent prostate cancer cells
Li-Jie Xiao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Targeting TNF-α to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
Arianna Calcinotto et al.
JOURNAL OF IMMUNOLOGY (2012)
Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
Zoran Culig et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
CXCR4 Expression in Prostate Cancer Progenitor Cells
Anna Dubrovska et al.
PLOS ONE (2012)
The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
Rajendra Kumar Singh et al.
CANCER RESEARCH (2011)
The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells
M. N. Thobe et al.
ONCOGENE (2010)
Intralesional recombinant α-interferon for localized prostate cancer: a pilot study with follow-up of >10 years
Laurel Emerson et al.
BJU INTERNATIONAL (2009)
Emerging roles of chemokines in prostate cancer
David Vindrieux et al.
ENDOCRINE-RELATED CANCER (2009)
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines
Shailesh Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Scavenger Chemokine (CXC Motif) Receptor 7 (CXCR7) Is a Direct Target Gene of HIC1 (Hypermethylated in Cancer 1)
Capucine Van Rechem et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
Jianhua Wang et al.
CANCER RESEARCH (2008)
被撤回的出版物: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (Retracted article. See vol. 298, 2022)
Jianhua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CXCL12 activates a robust transcriptional response in human prostate epithelial cells
Lesa A. Begley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CCR2 expression correlates with prostate cancer progression
Yi Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo et al.
NATURE REVIEWS CANCER (2007)
Expression of CCL5 (RANTES) and CCR5 in prostate cancer
GG Vaday et al.
PROSTATE (2006)
Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression
GA Heresi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2005)
Expression and functional role of CCR9 in prostate cancer cell migration and invasion
S Singh et al.
CLINICAL CANCER RESEARCH (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
F Curnis et al.
NATURE BIOTECHNOLOGY (2000)
分享论文
